… (DTaP–IPV–Hib, DTaP–HBV–Hib, DTaP–HBV–IPV–Hib) are safe, well-tolerated, and provide
immunogenic … The combined DTaP–HBV–IPV–Hib vaccine showed a higher incidence of …

… that the immunogenicity of the Hep … immunogenicity as a primary objective of this study.
The response to the remaining antigens was analyzed descriptively. Immunogenicity and safety …

… This study evaluated the immunogenicity and safety of a DTaP–IPV//PRP~T combination
vaccine given to infants as a primary series at 6, 10 and 14 weeks of age. The results were …

… of immunogenicity of DTaP-IPV//Hib pentavalent combination vaccine (Pentaxim™) compared
with licensed DTaP-IPV … separate DTaP-IPV and Hib vaccines (n = 206) or the pentavalent …

… This study was undertaken to evaluate the immunogenicity and … We measured DTaP–IPV
immunogenicity before and 1 month … 2 for responses to DTaP–IPV antigens according to pre-…

… However, it is essential that the immunogenicity and safety of … DTaP–IPV vaccine to be as
immunogenic and well-tolerated as separate administration of currently licensed DTaP and IPV …

… doses of DTaP vaccine. This study assessed the safety and immunogenicity of the DTaP–IPV …
of age compared with commercially available DTaP and IPV standalone control vaccines. …

… , acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV) to the elderly. This study
evaluated immune responses to and safety of the two vaccines administered concomitantly …

… demonstrate that the immunogenicity of dTap-IPV B is not inferior to that of dTap-IPV R (Repevax, …
of accepted correlate of protection for pertussis, the immunogenicity of dTap-IPV B was …

… The second booster with DTaP-IPV elicited a strong response … DTaP-IPV//PRP-T vaccine
induced satisfactory antibody persistence at 4-6 years of age. A second booster with DTaPIPV …